User Rating 0.0
Total Usage 0 times
Is this tool helpful?

Your feedback helps us improve.

About

Designing a robust clinical trial requires precise estimation of study power and sample size to avoid Type II errors (false negatives). Underpowered studies waste resources and may fail to detect clinically significant effects, while overpowered studies expose unnecessary numbers of patients to experimental interventions. This tool assists principal investigators and medical researchers in the planning phase of Randomized Control Trials (RCTs) and cohort studies.

Beyond sample size, accurate diagnostic interpretation relies on predictive values which are heavily influenced by disease prevalence - a factor often overlooked in generic calculators. This application computes Positive Predictive Value (PPV) and Negative Predictive Value (NPV) using Bayes' theorem, ensuring that sensitivity and specificity are contextualized within the target population's epidemiology.

sample size biostatistics clinical trials p-value sensitivity specificity ppv npv

Formulas

Sample Size (n) for comparing two means (Independent Samples):

n = 2σ2(Zα/2 + Zβ)2Δ2

Where Δ is the difference in means (Effect Size) and σ is standard deviation.

Predictive Values (Bayesian):

PPV = Sens × PrevSens×Prev + (1Spec)×(1Prev)

Reference Data

ParameterSymbolStandard Value (Medical)Description
Significance Levelα0.05Probability of Type I error (False Positive).
Power1-β0.80 (80%)Probability of correctly detecting an effect.
Effect Sized0.2 - 0.8Cohen's d: Small (0.2), Medium (0.5), Large (0.8).
Z-Score (95%)Zα/21.96Critical value for two-tailed test.
Z-Score (99%)Zα/22.576Critical value for high precision.
PrevalenceP0 to 1Prior probability of disease in population.
SensitivitySensHigh is betterTrue Positive Rate.
SpecificitySpecHigh is betterTrue Negative Rate.

Frequently Asked Questions

A test with 99% sensitivity can still have a low Positive Predictive Value (PPV) if the disease is extremely rare. In a population with 0.1% prevalence, false positives from the 99% specificity may outnumber true positives, leading to "Alarm Fatigue" in clinical settings.
Alpha (Type I) is seeing a difference when none exists (False Positive). Beta (Type II) is failing to see a difference that actually exists (False Negative). Medical trials usually tolerate a 5% chance of Alpha error but up to 20% Beta error (80% Power).
Use two-tailed (standard) if you want to detect if the treatment is either better OR worse. Use one-tailed only if it is impossible or irrelevant for the treatment to be worse than the control, which is rare in ethical medical research.
Effect size is often estimated from pilot studies, previous literature, or the "Minimum Clinically Important Difference" (MCID). If unknown, standard conventions (Cohen's d) are: 0.2 (Small), 0.5 (Medium), 0.8 (Large).